Hot flashes in postmenopausal women ameliorated by danazol

G. V. Foster, H. A. Zucur, J. A. Rock

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Six postmenopausal women with hot flashes were studied for two 8-week periods during which they received low-dose danazol (100 mg/24 hours) for one time interval and placebo for the other in a randomized double-blind manner. The patients recorded the number and severity of their hot flashes daily. On the last day of each period the patients were admitted to the research center overnight for an 8-hour monitoring of forehead skin temperatures and for continuous withdrawal of blood to determine 20-minute integrated levels of luteinizing hormone. Three of the six patients responded to danazol with a mean reduction of 88% in the number of hot flashes and a 53% decrease in the severity of hot flashes. Responders differed from nonresponders in that on treatment the frequency of nocturnal pulses of luteinizing hormone was reduced more (36.1% versus 14.4%), the increase in amplitude of the pulses was greater (+30.7% versus -11.8%), and the fall in the mean level of luteinizing hormone was more marked (19.0% versus 10.5%). The findings suggest that danazol may be a reasonable alternative to estrogen in the treatment of postmenopausal women with severe vasomotor symptoms.

Original languageBritish English
Pages (from-to)401-404
Number of pages4
JournalFertility and Sterility
Issue number3
StatePublished - 1985


Dive into the research topics of 'Hot flashes in postmenopausal women ameliorated by danazol'. Together they form a unique fingerprint.

Cite this